HLA-DQ associations and T-cell receptor V-gene usage in peripheral blood of Swedish myasthenia gravis patients

European Journal of Immunogenetics

Volumn 24, Issue 3, 1997, Pages 179-189

  Hjelmstrom P ^a,b   Giscombe, R ^a   Lefvert, A K ^a   Grunewald J ^a   Pirskanen, R ^a   Sanjeevi, C B ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ETIOLOGY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; GENETIC ASSOCIATION; HLA TYPING; HUMAN; HUMAN CELL; MALE; MYASTHENIA GRAVIS; OLIGONUCLEOTIDE PROBE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; THYMECTOMY;

EID: 0030998208     PISSN: 09607420     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2370.1997.00254.x     Document Type: Article

References (42)

1. ÅHLBERG, R., YI, Q., PIRSKANEN, R., MATELL, G., SWERUP, C., RIEBER, E.P., RIETMULLER, G., HOLM, G. & LEFVERT, A.K. (1994) Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivity. Neurology, 44, 1732.
2. ALTMANN, D.M., SANSOM, D. & MARSH, S.G.E. (1991) What is the basis for HLA-DQ associations with autoimmune disease? Immunology Today, 12, 267.
3. BERRIH, S., GAUD, C., BACH, M.A., BRIGAND, H.L., BINET, J.P. & BACH, J.F. (1981) Evaluation of T cell subsets in myasthenia gravis using anti-T-cell monoclonal antibodies. Clincial and Experimental Immunology, 45, 1.
4. BERRIH-AKNIN, S., COHEN-KAMINSKY, S. & TRUFFAULT, F. (1995) T-cell receptor expression in the thymus from patients with myasthenia gravis Annals of the New York Acadamy of Sciences, 756, 438.
5. CHRISTADOSS, P. & DAUPHINEE, MJ.. (1986) Immunotherapy for myasthenia gravis: a murine model. Journal of Immunology, 136, 2437.
6. + T cells Clincial and Experimental Immunology, 96, 364.
7. COMPSTON, D.A.S., VINCENT, A., NEWSOM-DAVIS, J. & BATCHELOR, J.R. (1990) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain, 103, 579.
8. + T cells. Implication for positive selection of T cells in man. European Journal of Immunology, 21, 1571.
9. DEGLI-ESPOSTI, M.A., ANDREAS, A., CHRISTIANSEN, F.T., SCHALKE, B., ALBERT, E. & DAWKINS, R.L. (1992) An approach to the localisation of the susceptibility genes for general myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics, 35, 355.
10. DRACHMAN, D.B. (1994) Myasthenia gravis. New England Journal of Medicine, 330, 1797.
11. ESCH, T., CLARK, L., ZHANG, X.-M., GOLDMAN, S. & HEBEK-KATZ, E. (1992) Observations, legends, and conjectures concerning restricted T-cell receptor usage and autoimmune disease. Critical Reviews of Immunology, 11, 249.
12. + T cell expansions in normal individuals and patients with rheumatoid arthritis Journal of Immunology, 154, 3538.
13. GIGLIOTTI, D., LEFVERT, A.K., JEDDITEHRANI, M., ESIN, S., HODARA, V., PIRSKANEN, R., WIGZELL, H. & ANDERSSON, R. (1996) Overexpression of selected T-cell receptor V-beta gene families within CD4 (+) and CD8 (+) T cell subsets of myasthenia gravis patients - a role for superantigen (s). Molecular Medicine, 2, 452.
14. GILHUS, N., WILLCOX, N., HARCOURT, G., NAGVEKAR, N., BEESON, D., VINCENT, A. & NEWSOM-DAVIS, J. (1995) Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. Journal of Neuroimmunology, 56, 65.
15. GISCOMBE, R., GRÜNEWALD, J., NITYANAND, S. & LEFVERT, A.K. (1995) TCR V gene usage in patients with systemic necrotizing vasculitis. Clincial and Experimental Immunology, 101, 213.
16. GRÜNEWALD, J. & WIGZELL, H. (1996) T-cell expansions in healthy individuals Immunologist, 4, 99.
17. GRÜNEWALD, J., ÅHLBERG, R., LEFVERT, A.-K., DERSIMONIAN, H., WIGZELI., H. & JANSON, C.H. (1991) Abnormal T-cell expansion and V-gene usage in myasthenia gravis patients. Scandinavian Journal of Immunology, 34, 161.
18. HJELMSTRÖM, P., GISCOMBE, R., LEFVERT, A.K., PIRSKANEN, R., KOCKUM, I., LANDIN-OLSSON, M. & SANJEEVI, C.B. (1995) Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis. Autoimmunity, 22, 59.
19. HJELMSTRÖM, P., GISCOMBE, R., LEFVERT, A.K., PIRSKANEN, R., KOCKUM, I., LANDIN-OLSSON, M. & SANJEEVI, C.B. (1996) Domains of polymorphic amino acids in the HLA-DQ molecule are associated with disease heterogeniety in myasthenia gravis. Journal of Neuroimmunology, 65, 125.
20. HOHLFELD, R. & WEKERLE, H. (1994) The role of the thymus in myasthenia gravis. Advances in Neuroimmunology, 4, 373.
21. HOHLFELD, R., TOYKA, K.V., HEININGER, K., GROSSE-WILDE, H. & KALIES, I. (1984) Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature, 310, 244.
22. HOHLFELD, R., TOYKA, K.V., TZARTOS, S.J., CARSON, W. & CONTI-TRONCONI, M. (1987) Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor a subunit. Proceedings of the National Acadamy of Sciences USA, 84, 5379.
23. LEFVERT, A.K., BERGSTROM, K., MATELL, G., OSTERMAN, P.O. & PIRSKANEN, R. (1978) Determination of acetylcholine receptor antibodies in myasthenia gravis: clinical usefulness and pathogenetic implications. Journal of Neurological Neurosurgery and Psychiatry, 41, 394.
24. LEHMANN, P., SERCARZ, E.E., FORSTHUBER, T., DAYAN, C.M. & GAMMON, G. (1993) Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunology Today, 14, 203.
25. MANTEGAZZA, R., OKSENBERG, J.R., BAGGI, F., ANTOZZI, C., ILLENI, M.T., PELLEGRIS, G., CORNELIO, F. & STEINMAN, L. (1990) Increased incidence of certain TCR and HLA genes associated with myasthenia gravis in Italians. Journal of Autoimmunity, 3, 431.
26. MASELLI, R., RICHMAN, D.P. & WOLLMAN, R.L. (1991) Inflammation at the neuromuscular junction in myasthenia gravis. Neurology, 41, 1497.
27. MORGUTTI, M., CONTI-TRONCONI, B.M., SGHIRLANZONI, A. & CLEMENTI, F. (1979) Cellular immune response to acetylcholine receptor in myasthenia gravis. II. Thymectomy and corticosteroids. Neurology, 29, 734.
28. OFFNER, H., BUENAFE, A.C., VAINIENE, M., CELNIK, B., WEINBERG, A.D., GOLD, D.P., HASHIM, G. & VANDENBARK, A.A. (1993) Where, when, and how to detect biased expression of disease-relevant Vβ genes in rats with experimental autoimmune encephalomyelitis. Journal of Immunology, 151, 506.
29. OKSENBERG, J.R., SHERRITT, M., BEGOVICH, A.B., ERLICH, H.A., BERNARD, C.C., CAVALLI-SKORZA, L.L. & STEINMAN, L. (1989) T-cell receptor Vα and Cα alleles associated with multiple sclerosis and myasthenia gravis. Proceedings of the National Academy of Sciences USA, 86, 988.
30. OLERUP, O. & ZETTERQUIST, H. (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens, 39, 225.
31. OOSTERHUIS, H.J.G.H. (1964) Studies in myasthenia gravis. Journal of Neurological Science, 1, 512.
32. OTTENHOFF, T., WALFORD, C., NISHIMURA, Y., REDDY, N.B. & SASAZUKI, T. (1990) HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients. European Journal of Immunology, 20, 2347.
33. PAPATESTAS, A., GENKINS, G., KORNFELD, P., EISENKRAFT, J.B., FAGERSTROM, R.P., POZNER, J. & AUFSES, A.H. (1987) Effects of thymectomy in myasthenia gravis. Annals of Surgery, 206, 79.
34. PASCUZZI, R. & CAMPA, J.F. (1988) Lymphorrage localized to the muscle endplate in myasthenia gravis. Archives of Pathological and Laboratory Medicine, 112, 934.
35. PIRSKANEN, R., THILIKAINEN, A. & HOKKANEN, E. (1972) Histocompatibilily (HL-A) antigens associated with myasthenia gravis. Annals of Clincial Reviews, 4, 304.
36. POSNETT, D.N., SINHA, R., KABAK, S. & RUSSO, C. (1994) Clonal populations of T cells in normal elderly humans: the T cell equivalent to 'benign monoclonal gammapathy'. Journal of Experimental Medicine, 179, 609.
37. SANJEEVI, C.B., SESHIAH, V., MÖLLER, E. & OLERUP, O. (1992) Different genetic backgrounds for malnutrition-related diabetes and Type 1 (insulin-dependent) diabetes mellitus in South Indians. Diabetologia, 35, 283.
38. SMITH, C.I.E., BORGONOVO, L., CARLSSON, B., HAMMARSTRÖM. L. & RABBITTS, T.H. (1987) Molecular probing of disease suceptibility in myasthenia gravis patients: an analysis of T-cell receptor and HLA class II genes using restriction fragment lenght polymorphism. Annals of the New York Acadamy of Sciences, 505, 388.
39. SPURKLAND, A., GILHUS, N.E., RØNNINGEN, K.S., AARLI, J.A. & VARTDAL, F. (1991) Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations. Tissue Antigens, 37, 90.
40. TESCH, H., HOHLFELD, R. & TOYKA, K.V. (1989) Analysis of immunoglobulin and T cell receptor gene rearrangements in the thymus of myasthenia gravis patients. Journal of Neuroimmunology, 21, 169.
41. TOURNIER-LASSERVE, E. & BACH, J.-F. (1993) The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models. Journal of Neuroimmunology, 47, 103.
42. VIEIRA, M.L., CAILLAT-ZUCMAN, S., GAJDOS, P., COHEN-KAMINSKY, S., CASTEUR, A. & BACH, J.-F. (1993) Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. Journal of Neuroimmunology, 47, 115.